Information Provided By:
Fly News Breaks for May 12, 2015
BDSI
May 12, 2015 | 07:00 EDT
Cantor cut its price target on BioDelivery Sciences,citing discounts on the company's BUNAVAIL drug for opioid dependence and lower than expected expected Q1 revenue from the drug. The firm, however, still thinks the company has several near-term catalysts and expects the stock to appreciate later in the year. It keeps a Buy rating on the stock.
News For BDSI From the Last 2 Days
There are no results for your query BDSI